• xbxc1

OEM Supply Bromhexine Hydrochloride Oral Solution - Tilmicosin Oral Solution 10% – Lihua

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our objective is to present premium quality products at aggressive prices, and top-notch services to buyers around the world. We have been ISO9001, CE, and GS certified and strictly adhere to their excellent specifications for Tylosin Pills, Ivermectin And Clorsulon Injection, Tilmicosin Soluble Powder, We are hunting ahead to cooperating with all buyers from in your own home and abroad. Moreover, customer pleasure is our everlasting pursuit.
OEM Supply Bromhexine Hydrochloride Oral Solution - Tilmicosin Oral Solution 10% – Lihua Detail:

Tilmicosin is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.

Indications

Macrotyl-250 Oral is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and swine.

Contra-Indications

Hypersensitivity or resistance to tilmicosin.

Concurrent administration of other macrolides or lincosamides.

Administration to animals with an active microbial digestion or to equine or caprine species.

Parenteral administration, especially in porcine species.

Administration to poultry producing eggs for human consumption or to animals intended for breeding purposes.

During pregnancy and lactation, use only after a risk/benefit assessment by a veterinarian.

Side Effects

Occasionally, a transient reduction in water or (artificial) milk intake has been observed upon treatment with tilmicosin.

Administration and Dosage

For oral administration.

Calves : Twice daily, 1 ml per 20 kg body weight via (artificial) milk for 3 – 5 days.

Poultry : 300 ml per 1000 litre drinking water (75 ppm) for 3 days.

Swine : 800 ml per 1000 litre drinking water (200 ppm) for 5 days.

Note: Medicated drinking water or (artificial) milk should be prepared fresh every 24 h. To ensure a correct dosage, the concentration of the product should be adjusted to the actual fluid intake.

Withdrawal Time

- For meat:

Calves : 42 days.

Broilers : 12 days.

Turkeys : 19 days.

Swine : 14 days.

For Veterinary UseOnly , Keep out of reach of children


Product detail pictures:


Related Product Guide:

"Control the quality by the details, show the strength by quality". Our company has strived to establish a highly efficient and stable staff team and explored an effective quality control process for OEM Supply Bromhexine Hydrochloride Oral Solution - Tilmicosin Oral Solution 10% – Lihua , The product will supply to all over the world, such as: Albania, Kuala Lumpur, Swansea, We set a strict quality control system. We have return and exchange policy, and you can exchange within 7 days after receive the wigs if it is in new station and we service repairing free for our products. Please feel free to contact us for further information and we will offer you competitive price list then.
  • Previous
  • Next:

  • Staff is skilled, well-equipped, process is specification, products meet the requirements and delivery is guaranteed, a best partner!
    5 Stars By Jodie from Colombia - 2018.12.11 11:26
    The customer service staff's answer is very meticulous, the most important is that the product quality is very good, and packaged carefully, shipped quickly!
    5 Stars By Quyen Staten from Swiss - 2018.11.04 10:32